Target Name: ZMAT1
NCBI ID: G84460
Review Report on ZMAT1 Target / Biomarker Content of Review Report on ZMAT1 Target / Biomarker
ZMAT1
Other Name(s): KIAA1789 | MGC176597 | MGC176728 | Zinc finger matrin-type protein 1 | ZMAT1 variant 1 | ZMAT1_HUMAN | Zinc finger, matrin type 1 | OTTHUMP00000023703 | zinc finger matrin-type 1 | Zinc finger, matrin type 1 (isoform 1) | Zinc finger, matrin type 1, transcript variant 1

ZMAT1: A Potential Drug Target for Various Diseases

ZMAT1 (KIAA1789) is a protein that is expressed in various tissues throughout the body, including the brain. It is a member of the KIAA family of proteins, which are known for their role in cell signaling. ZMAT1 has been shown to play a role in the development and progression of various diseases, including cancer. As a result, ZMAT1 has generated a lot of interest as a potential drug target or biomarker.

One of the key functions of ZMAT1 is its role in the regulation of cell growth and differentiation. This protein is known to play a key role in the inhibition of cell proliferation. In fact, studies have shown that high levels of ZMAT1 can inhibit the growth of cancer cells, suggesting that it may be an effective target for cancer therapies.

Another function of ZMAT1 is its role in the regulation of cell survival. This protein has been shown to play a key role in the regulation of cell survival, and high levels of ZMAT1 have been associated with poor cell survival. This suggests that ZMAT1 may be an effective target for diseases that are characterized by poor cell survival, such as cancer.

In addition to its role in cell growth and survival, ZMAT1 has also been shown to play a key role in the regulation of cellular processes that are important for normal brain function. This protein is known to play a key role in the regulation of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain. As a result, ZMAT1 may be an effective target for diseases that are characterized by problems with the blood-brain barrier, such as Alzheimer's disease.

Another potential function of ZMAT1 is its role in the regulation of inflammation. This protein has been shown to play a key role in the regulation of inflammation, and high levels of ZMAT1 have been associated with increased inflammation. This suggests that ZMAT1 may be an effective target for diseases that are characterized by inflammation, such as rheumatoid arthritis.

In addition to its role in cell signaling, ZMAT1 has also been shown to play a key role in the regulation of cellular processes that are important for normal tissue repair and regeneration. This protein is known to play a key role in the regulation of the Wnt signaling pathway, which is responsible for the regulation of cell growth and differentiation. As a result, ZMAT1 may be an effective target for diseases that are characterized by problems with tissue repair and regeneration, such asWilson's disease.

Overall, ZMAT1 is a protein that has been shown to play a key role in a variety of cellular processes that are important for normal tissue function. As a result, this protein has generated a lot of interest as a potential drug target or biomarker. Further research is needed to fully understand the role of ZMAT1 in disease progression and to determine its potential as a therapeutic agent.

Protein Name: Zinc Finger Matrin-type 1

The "ZMAT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZMAT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232